Theravance Biopharma IncNASDAQ:TBPH
- LAST PRICE9.4700
- TODAY'S CHANGE (%)-0.1400 (-1.4568%)
- Bid / Lots9.3500/ 1
- Ask / Lots9.8500/ 1
- Open / Previous Close9.5900 / 9.6100
- Day Range
- 52 Week Range
- Volume340,347
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TBPH |
|---|---|---|
| 09:32 ET | 2789 | 9.56 |
| 09:37 ET | 100 | 9.68 |
| 09:42 ET | 100 | 9.685 |
| 09:44 ET | 400 | 9.75 |
| 09:51 ET | 1412 | 9.69 |
| 09:55 ET | 100 | 9.64 |
| 09:57 ET | 500 | 9.7 |
| 10:02 ET | 100 | 9.665 |
| 10:04 ET | 6631 | 9.605 |
| 10:06 ET | 100 | 9.605 |
| 10:08 ET | 619 | 9.59 |
| 10:09 ET | 400 | 9.59 |
| 10:11 ET | 320 | 9.59 |
| 10:15 ET | 400 | 9.595 |
| 10:20 ET | 200 | 9.595 |
| 10:22 ET | 740 | 9.57 |
| 10:24 ET | 704 | 9.54 |
| 10:26 ET | 330 | 9.545 |
| 10:27 ET | 1500 | 9.515 |
| 10:29 ET | 398 | 9.5 |
| 10:31 ET | 4579 | 9.525 |
| 10:33 ET | 234 | 9.524 |
| 10:36 ET | 142 | 9.515 |
| 10:40 ET | 537 | 9.515 |
| 10:42 ET | 100 | 9.5 |
| 10:44 ET | 100 | 9.515 |
| 10:45 ET | 1200 | 9.515 |
| 10:47 ET | 877 | 9.515 |
| 10:49 ET | 300 | 9.515 |
| 10:51 ET | 200 | 9.515 |
| 10:56 ET | 100 | 9.515 |
| 10:58 ET | 2107 | 9.505 |
| 11:00 ET | 200 | 9.505 |
| 11:02 ET | 100 | 9.505 |
| 11:05 ET | 110 | 9.505 |
| 11:07 ET | 100 | 9.49 |
| 11:09 ET | 200 | 9.505 |
| 11:14 ET | 2477 | 9.485 |
| 11:16 ET | 600 | 9.485 |
| 11:18 ET | 100 | 9.485 |
| 11:20 ET | 600 | 9.48 |
| 11:21 ET | 300 | 9.46 |
| 11:23 ET | 2200 | 9.45 |
| 11:25 ET | 1600 | 9.45 |
| 11:27 ET | 600 | 9.45 |
| 11:30 ET | 335 | 9.445 |
| 11:34 ET | 2701 | 9.46 |
| 11:38 ET | 500 | 9.43 |
| 11:39 ET | 100 | 9.425 |
| 11:41 ET | 200 | 9.425 |
| 11:45 ET | 100 | 9.425 |
| 11:48 ET | 465 | 9.425 |
| 11:50 ET | 400 | 9.425 |
| 11:52 ET | 100 | 9.425 |
| 11:54 ET | 300 | 9.425 |
| 11:56 ET | 200 | 9.425 |
| 11:57 ET | 200 | 9.43 |
| 12:01 ET | 400 | 9.4275 |
| 12:03 ET | 1179 | 9.44 |
| 12:06 ET | 200 | 9.44 |
| 12:10 ET | 290 | 9.439 |
| 12:12 ET | 100 | 9.44 |
| 12:15 ET | 100 | 9.44 |
| 12:19 ET | 100 | 9.44 |
| 12:21 ET | 2749 | 9.41 |
| 12:24 ET | 200 | 9.41 |
| 12:26 ET | 200 | 9.41 |
| 12:30 ET | 100 | 9.41 |
| 12:32 ET | 780 | 9.4 |
| 12:33 ET | 400 | 9.4 |
| 12:35 ET | 100 | 9.4 |
| 12:37 ET | 200 | 9.39 |
| 12:39 ET | 100 | 9.38 |
| 12:42 ET | 100 | 9.37 |
| 12:44 ET | 202 | 9.37 |
| 12:46 ET | 100 | 9.37 |
| 12:50 ET | 500 | 9.375 |
| 12:53 ET | 16351 | 9.51 |
| 12:55 ET | 100 | 9.515 |
| 01:04 ET | 600 | 9.515 |
| 01:06 ET | 400 | 9.52 |
| 01:08 ET | 100 | 9.52 |
| 01:09 ET | 400 | 9.52 |
| 01:11 ET | 400 | 9.54 |
| 01:13 ET | 6917 | 9.45 |
| 01:15 ET | 100 | 9.47 |
| 01:18 ET | 200 | 9.49 |
| 01:20 ET | 101 | 9.47 |
| 01:24 ET | 100 | 9.47 |
| 01:26 ET | 100 | 9.47 |
| 01:27 ET | 400 | 9.47 |
| 01:29 ET | 5411 | 9.46 |
| 01:38 ET | 101 | 9.465 |
| 01:44 ET | 130 | 9.465 |
| 01:45 ET | 400 | 9.46 |
| 01:47 ET | 794 | 9.46 |
| 01:49 ET | 606 | 9.46 |
| 01:51 ET | 1540 | 9.465 |
| 01:54 ET | 1600 | 9.475 |
| 01:58 ET | 100 | 9.48 |
| 02:00 ET | 401 | 9.5 |
| 02:02 ET | 2846 | 9.48 |
| 02:03 ET | 101 | 9.495 |
| 02:07 ET | 100 | 9.52 |
| 02:09 ET | 250 | 9.5258 |
| 02:12 ET | 100 | 9.53 |
| 02:14 ET | 100 | 9.53 |
| 02:16 ET | 200 | 9.54 |
| 02:20 ET | 601 | 9.61 |
| 02:21 ET | 100 | 9.62 |
| 02:23 ET | 100 | 9.63 |
| 02:27 ET | 1888 | 9.68 |
| 02:30 ET | 500 | 9.665 |
| 02:32 ET | 4020 | 9.615 |
| 02:36 ET | 100 | 9.62 |
| 02:38 ET | 500 | 9.64 |
| 02:39 ET | 100 | 9.62 |
| 02:43 ET | 205 | 9.61 |
| 02:45 ET | 802 | 9.62 |
| 02:48 ET | 300 | 9.61 |
| 02:50 ET | 200 | 9.6 |
| 02:52 ET | 100 | 9.6 |
| 02:54 ET | 1200 | 9.58 |
| 02:56 ET | 1431 | 9.58 |
| 02:59 ET | 100 | 9.58 |
| 03:03 ET | 809 | 9.56 |
| 03:06 ET | 600 | 9.545 |
| 03:08 ET | 762 | 9.545 |
| 03:10 ET | 200 | 9.545 |
| 03:12 ET | 201 | 9.545 |
| 03:14 ET | 300 | 9.545 |
| 03:15 ET | 100 | 9.555 |
| 03:17 ET | 200 | 9.555 |
| 03:19 ET | 205 | 9.555 |
| 03:24 ET | 301 | 9.555 |
| 03:26 ET | 4442 | 9.525 |
| 03:28 ET | 408 | 9.525 |
| 03:30 ET | 200 | 9.525 |
| 03:32 ET | 100 | 9.525 |
| 03:33 ET | 7408 | 9.5 |
| 03:35 ET | 1155 | 9.515 |
| 03:37 ET | 1832 | 9.525 |
| 03:39 ET | 100 | 9.525 |
| 03:42 ET | 4225 | 9.525 |
| 03:44 ET | 100 | 9.53 |
| 03:46 ET | 1635 | 9.53 |
| 03:48 ET | 898 | 9.52 |
| 03:50 ET | 100 | 9.52 |
| 03:51 ET | 2989 | 9.53 |
| 03:53 ET | 3409 | 9.505 |
| 03:55 ET | 1404 | 9.51 |
| 03:57 ET | 1211 | 9.5 |
| 04:00 ET | 51362 | 9.47 |
Nov 20, 2024
Theravance Biopharma to Participate in an Upcoming Investor Conference, from 6:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
6:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 13, 2024
DJ Theravance Biopharma Up Over 10%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk, from 11:56AM ET on Wednesday Nov 13, 2024 by Dow Jones
11:56AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones*DJ Theravance Biopharma 3Q Loss/Shr 26c >TBPH, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 24, 2024
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024, from 6:00AM ET on Thursday Oct 24, 2024 by Dow Jones
6:00AM ET on Thursday Oct 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Theravance Biopharma Inc | 470.1M | -9.4x | --- |
Aquestive Therapeutics Inc | 411.2M | -10.1x | --- |
Daiichi Sankyo Co Ltd | 56.2B | 34.0x | --- |
EyePoint Pharmaceuticals Inc | 568.6M | -4.5x | --- |
Sanara Medtech Inc | 326.4M | -38.2x | --- |
Esperion Therapeutics Inc | 486.7M | -3.8x | --- |
Company Information
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is a prescription medicine used to treat COPD, a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath, and others. Ampreloxetine, its late-stage investigational norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension.
Contact Information
- Headquarters
- UGLAND HOUSE, SOUTH CHURCH STREETGEORGE TOWN, Cayman Islands KY1-1104
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Rick Winningham
- Chief Financial Officer, Senior Vice President
- Aziz Sawaf
- Senior Vice President, General Counsel, Secretary
- Brett Grimaud
- Senior Vice President - Commercial and Medical Affairs, Chief Business Officer
- Rhonda Farnum
- Senior Vice President - Development and Head of Ireland Office
- Aine Miller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $463.3M |
|---|---|
Revenue (TTM) | $63.2M |
Shares Outstanding | 48.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.23 |
EPS | $-1.01 |
Book Value | $4.43 |
P/E Ratio | -9.4x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -69.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
